科技配消费,越配越对味(共16份)
科技行业辅助消费崛起
-
艾媒咨询|2021年3-4月中国母婴行业月度运行数据监测报告
本报告研究涉及企业/品牌/案例:贝康医疗,锦欣生殖,美吉姆,红黄蓝
在人口老龄化加速发展的背景下,我国的生育政策保持利好。但是受到晚婚晚育及二孩大龄母亲等影响,辅助生育产业得到高速发展,2020年的市场规模达到354.73亿元。同时,婴儿早教行业在疫情后回复发展,iiMedia Research(艾媒咨询)数据显示,2021年,中国家长在挑选早教课程的考虑因素中,最重要的是早教内容的专业度和丰富度,占比分别高达64.1%和63.3%。
In the context of the accelerated development of population production, the birth policy has been maintained well. At the same time, early childhood education is affected by marriage and parenting and older mothers with two children, and the assisted reproductive industry has been developed. The market size in 2020 will reach 354.73. At the same time, the infant early education industry has resumed development after the epidemic was revealed. According to data from iiMedia Research, in 2021, among the factors that Chinese parents consider when choosing early education courses, the most important factor is the professionalism and degree of early education content, which will eventually be as high as 64.1% and 63.3%. -
艾媒报告|2020-2021年中国口罩行业市场状况与趋势研究报告
本报告研究涉及企业/品牌/案例:兴诺科技,阳普医疗,振德医疗,泰达股份,南卫股份,蓝帆医疗,道恩股份,诺邦股份,欣龙控股,中国石化,上汽通用五菱,比亚迪,爹地宝贝,扬州米奇科技,富士康,3M,绿盾,霍尼韦尔,保为康POWECOM,CM朝美,UVEX优唯斯,南丁,云南白药,维康WECAN,振德医疗,白元HAKUGEN,稳健WINNER,PURAVATION普卫欣,滴露,仁和药业
2020年2月19日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国口罩行业市场状况与趋势研究报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对中国口罩行业的发展现状以及产业链细分领域进行深度分析,以欣龙控股、兴诺科技、阳普医疗等口罩企业为典型进行商情分析,深入探究运行模式和发展趋势。近几年中国口罩产业产值及产量均保持约10%的高速稳定增长,而2020年的新冠病毒疫情,令口罩从非必备常态的产品转变为必备的临时防护用品,预计2020年口罩将领跑中国防护用品领域。然而艾媒咨询分析师认为,2020下半年至2021年,口罩行业可能面临严重的产能过剩问题,如何通过提高口罩品质、品牌价值以增加口罩产品的附加值和出口海外的竞争力是行业发展的关键。
In recent years, the output value and output of China's mask industry have maintained a rapid and stable growth of about 10%. The COVID-19 epidemic will transform masks into necessary temporary protective supplies in 2020. However, iiMedia Consulting remind that from the second half of 2020 to 2021, the mask industry may face serious overcapacity. How to increase the quality of masks and brand value to increase the added value of mask products and the competition for export overseas that is the key to the development of the industry . -
艾媒报告 |2019全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:天猫医馆,七乐康,京卫大药房,阿里健康大药房,京东大药房,健客, 1药网,360好药,八百方,818医药网,CVS,Walgreens ,RiteAid ,开心人网上药店,药房网,药材买卖网,珍材网,中药材天地网,商康网,科欣医药,医药在线,我的医药网,药品交易网,药品终端网,药师帮,海王晨星,快方送药,药给力,搜药送,药急送,U医U药,叮当送药,健客网上药店,康爱多掌上药店,问药,好药师,111集团,中宏保险,医联,腾讯,仁和药业,浙江扁鹊,漱玉平民,华人健康,一树药业,德生堂
2019中国医药电商主要形成了B2C、B2B、O2O三种模式,B2C模式体量稳定在6%左右,规模呈增长趋势,预计2019年的市场交易额将达到554.6亿元;B2B模式下,西药类产品的需求比例较高,达87.1%,中药材、传统药品和第三方交易等都形成了专属B2B平台;而近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,但区域覆盖度和消费者的信任度需要提高。iiMedia Research(艾媒咨询)大数据监测显示,目前1药网、健客网上药店、康爱多掌上药店的的综合实力排行较强。
2019 China's pharmaceutical e-commerce mainly formed three modes of B2C, B2B and O2O. The volume of B2C model is stable at around 6%, and the scale is increasing. It is expected that the market transaction volume in 2019 will reach 55.46 billion yuan; in B2B mode, western medicine The demand ratio of products is relatively high, reaching 87.1%. Chinese herbal medicines, traditional medicines and third-party transactions have formed a proprietary B2B platform. In recent years, the O2O model has emerged mainly through “drainage-conversion-consumption-feedback”. Achieve profitability, but regional coverage and consumer trust need to be improved. iiMedia Research (Ai Media Consulting) big data monitoring shows that the current comprehensive strength of 1 drug network, Jianke online pharmacy, Kang Aiduo pharmacy is strong. -
艾媒报告 |2019中国人造肉产业研究与消费者行为调查报告
本报告研究涉及企业/品牌/案例:Beyond Meat,Impossible Foods,杜邦,Ripple Foods,Bolthouse Farms,Roquette,Field Roast,Gardein,Mosa Meat,Modern Meadow,Finless Foods,烟台双塔食品,深圳齐善食品,宁波素莲素食,江苏鸿旭食品,万达财富,来伊份,登海种业,大北农,新开疆,京粮控股,四环生物,九芝堂,ST天宝,友好集团,爱普股份,丰乐种业,北大荒,天士力,中源协和,大康农业,东宝生物,融捷健康,华宝股份,戴维医疗,千红制药,金健米业,圣济堂,济民制药,哈高科,国际医学,维维股份,海欣食品,复星医药,苏常柴A,瑞茂通
人造肉主要包括植物肉、培育肉和混合肉三类。随着全球肉类短缺危机、健康与环保的消费风潮、食品创新推动等因素带动人造肉产业发展,资本市场开始关注人造肉产业,例如,Beyond Meat上市股市表现良好,Impossible Foods已完成超过6.875亿美元的多轮融资。中国的人造肉市场也开始发展,艾媒商情舆情数据监测系统显示,广东网民最关注人造肉议题。在资本和舆论的带动下,A股市场人造肉版块的活跃,同时,各类人造肉的上游产业链如大豆、豌豆蛋白、胎牛血清等开始共同发展。iiMedia Research(艾媒咨询),36%的中国消费者并不了解人造肉,同时低于四成消费者愿意尝试人造肉。艾媒咨询分析师认为,人造肉要真正市场化普及仍需克服成本、技术、消费者心理因素等多重障碍。
Artificial meat mainly includes three types of plant meat, cultivated meat and mixed meat. With the global meat shortage crisis, the consumption trend of health and environmental protection, and the promotion of food innovation, the capital market has begun to focus on the artificial meat industry. For example, Beyond Meat listed stocks performed well, and Impossible Foods has completed more than 687.5 million. Multiple rounds of financing for the dollar. China's artificial meat market has also begun to develop, and the iiMedia Research business data analysis system shows that Guangdong netizens are most concerned about artificial meat issues. Driven by capital and public opinion, the artificial meat section of the A-share market is active. At the same time, the upstream industrial chains of various types of artificial meat, such as soybean, pea protein and fetal bovine serum, have begun to develop together. iiMedia Research, 36% of Chinese consumers do not know about artificial meat, and less than 40% of consumers are willing to try artificial meat. Ai Media Consulting analysts believe that the real marketization of artificial meat still needs to overcome multiple obstacles such as cost, technology and consumer psychological factors. -
艾媒研报|石头科技:势能转换初见成效,自主发展仍待时日
本报告研究涉及企业/品牌/案例:小米集团、米家、石头、小瓦、天津金米、顺为、伊莱克斯、三叶虫、iRobot、Roomba、康力优蓝、狗尾草、中科机器人、小鱼儿、科沃斯、极思维、福玛特、天智航、钛米机器人、柏惠维康、艾米机器人、奇虎360、鑫益嘉、康力优蓝、智位机器人、优必选、科大讯飞、智臻智能、穿山甲、智点未来、有个机器人、深之蓝、博雅工道、祈飞科技、纳恩博、旗瀚科技、阿亦睿、超人机器人、飞利浦、浦桑尼克、欣旺达、京东、苏宁、唯品会、亚马逊、天猫、有品、小米集团、紫光、慕晨、国机
在政策、经济、技术、人口等因素的驱动下,服务机器人行业快速发展,并呈现出比比工业机器人更为广阔的市场空间。iiMedia Research(艾媒咨询)数据显示,预计到2020年,中国服务机器人年销售额将超过300亿元。扫地机器人在整个服务机器人市场是非常重要的一个细分领域,产品相对成熟,竞争也较为激烈。市场参与者包括新兴服务机器人公司、传统家电公司、互联网公司以及各种创业公司等,目前在国内主流电商平台上销售的智能扫地机器人品牌已近 200 个,其中头部品牌效应较为明显。石头科技作为专注于智能清洁机器人领域的科技企业,在小米集团的协助下快速发展,并于2017年开始推出自有品牌,为公司营收增长注入新动能。2018年石头科技营收30.5亿元,其中自有品牌贡献过半。虽然石头科技在业务发展方面有所调整,但想要完全脱离小米实现自主发展还需要时间。
Driven by factors such as policy, economy, technology and population, the service robot industry has developed rapidly and presents a broader market space than industrial robots. According to iiMedia Research, it is estimated that by 2020, the annual sales of service robots in China will exceed 30 billion yuan. Sweeping robots are a very important segment in the entire service robot market. The products are relatively mature and the competition is fierce. Market participants include emerging service robot companies, traditional home appliance companies, Internet companies, and various startup companies. Currently, there are nearly 200 smart sweeping robot brands sold on mainstream domestic e-commerce platforms, of which the head brand effect is more obvious. As a technology company specializing in intelligent cleaning robots, Roborock has developed rapidly with the assistance of Xiaomi Group. In 2017, it launched its own brand and injected new momentum into the company's revenue growth. In 2018, Roborock's revenue was 3.05 billion yuan, of which half of its own brands contributed. Although Roborock has made adjustments in its business development, it will take time to completely realize its independent development from Xiaomi. -
艾媒报告 |2019年中国柔性显示产业研究与商业投资决策分析报告
本报告研究涉及企业/品牌包括:三星、iPhone、华为、小米、OPPO、京东方、深天马A、TCL集团、微信诺、华星光电、信利国际、和辉光电、柔宇科技、中能源、湖南群显、联得装备、同兴达、志云股份、国风塑业、新纶科技、时代新材、鼎龙股份、激智科技、晶华新材、万润股份、强力新材、东旭光电、莱宝高科、长信科技、ST康得新、中颖电子、士兰微、凯盛科技、康达新材、西部材料、传艺科技、金明精机、光莆股份、样子想你才、神宇股份、海顺新材、茂硕电源
政策支持和技术进步共同推动中国柔性显示产业快速发展。iiMedia Research(艾媒咨询)监测发现,2018年中国柔性显示游产业链各个环节相关企业营收均超亿元,相关上市公司中京东方A(000725.SZ)的网络关注度最高,隆华科技(300263.SZ)的网络口碑最好。但由于技术门槛高等相关因素影响,中国柔性显示产业上游发展基础薄弱,产业存在发展不成熟、技术欠缺和市场份额不足等问题。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告